Celera Divests Animal Genomics Business
By Biotechdaily staff writers
Posted on 21 May 2002
The AgGen animal genomics and genotyping business of Celera Genomics (Rockville, MD, USA) has been sold to MetaMorphix, Inc. (Savage, MD, USA). In addition, MetaMorphix has received a subscription to the Celera Discovery System, providing access to Celera's livestock genomic databases. Celera has acquired a minority interest in MetaMorphix and is entitled to share future revenue generated from products developed by MetaMorphix based on Celera's livestock databases.Posted on 21 May 2002
MetaMorphix has 13 products in development, based on three technology platforms: growth factors, genomics/proteomics, and immunopharmaceuticals. The company's products are designed to increase the growth rate and meat production of livestock, improve feed efficiency, reduce waste, and decrease reliance on antibiotics and hormones.
"The creation of livestock genomic databases represents a quantum leap in the development of new products for the animal health and livestock production industries,” said Ed Quattlebaum, Ph.D., chairman, CEO, and president of MetaMorphix. "It is as historic to these industries as similar developments in the human health industry.”
Related Links:
Celera
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
New
Blood Glucose Test Strip
AutoSense Test
New
Gold Member
Hematology Analyzer
Medonic M32B
